Literature DB >> 11514424

Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment.

B G Nedrebø1, O Nygård, P M Ueland, E A Lien.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514424

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

1.  Restoration of euthyroidism does not improve cardiovascular risk factors in patients with subclinical hypothyroidism in the short term.

Authors:  Z Beyhan; K Ertürk; G Uçkaya; E Bolu; H Yaman; M Kutlu
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

2.  Effects of folic acid plus levothyroxine on serum homocysteine level in hypothyroidism.

Authors:  Amir Ziaee; Nader Hajibagher Tehrani; Zahra Hosseinkhani; Amir Kazemifar; Amir Javadi; Toktam Karimzadeh
Journal:  Caspian J Intern Med       Date:  2012

3.  Role of surrogate markers of atherosclerosis in clinical and subclinical thyroidism.

Authors:  Mehmet Gunduz; Ercan Gunduz; Fatih Kircelli; Nazan Okur; Mesut Ozkaya
Journal:  Int J Endocrinol       Date:  2012-02-23       Impact factor: 3.257

4.  Association between Hyperhomocysteinemia and Thyroid Hormones in Euthyroid Diabetic Subjects.

Authors:  Yun Zhang; Qiong Wang; Quanzhong Li; Ping Lu
Journal:  Biomed Res Int       Date:  2015-06-21       Impact factor: 3.411

5.  Homocysteine and fibrinogen changes with L-thyroxine in subclinical hypothyroid patients.

Authors:  Başak Cakal; Erman Cakal; Berrin Demirbaş; Mesut Ozkaya; Selma Karaahmetoğlu; Rüştü Serter; Yalçin Aral
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

6.  Serum homocysteine levels are decreased in levothyroxine-treated women with autoimmune thyroiditis.

Authors:  Maciej Owecki; Jolanta Dorszewska; Nadia Sawicka-Gutaj; Anna Oczkowska; Michał K Owecki; Michał Michalak; Jakub Fischbach; Wojciech Kozubski; Marek Ruchała
Journal:  BMC Endocr Disord       Date:  2014-03-01       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.